Canada markets closed

Creative Medical Technology Holdings, Inc. (CELZ)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.4100+0.0100 (+2.50%)
At close: 12:59PM EST
0.4400 +0.03 (+7.32%)
After hours: 04:49PM EST

Creative Medical Technology Holdings, Inc.

211 East Osborn Road
Phoenix, AZ 85012
United States
480 399 2822
https://www.creativemedicaltechnology.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees4

Key Executives

NameTitlePayExercisedYear Born
Mr. Timothy WarbingtonChairman, Pres & CEO98.68kN/A1962
Mr. Donald DickersonSr. VP, CFO & Director87.5kN/A1965
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Corporate Governance

Creative Medical Technology Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.